What's new! CIDG Publications July/August 2021
To assess the efficacy and safety of ivermectin compared to no treatment, standard of care, placebo, or any other proven intervention for people with COVID‐19 receiving treatment as inpatients or outpatients, and for prevention of an infection with SARS‐CoV‐2 (postexposure prophylaxis).
New CIDG review assesses the effect of community administration of ivermectin on malaria transmission
What's new! CIDG Publications June 2021
During May, READ-It Partners published the following reviews, and articles.
What's new! CIDG Publications May 2021
From February 2021 to March 2021, READ-It Partners published the following protocols, reviews, and articles.
We are currently recruiting a Clinical Research Associate and a Research Assistant in Evidence Synthesis, and a Research Assistant/Associate (medical statistician)
What's new! CIDG publications March 2021
While most national and health system‐level guidance is evidence based, how did we get into such a chaotic and confusing situation with the assessment of chloroquine and hydroxychloroquine efficacy?
Cochrane Library releases updated Special Collection on diagnosing tuberculosis to mark World Tuberculosis Day
Paul Garner: for months I have been through a roller coaster of ill health, extreme emotions, and utter exhaustion